3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Phase 1/2
1
Status
Recruiting
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Lymphoid
1
Breast
1
Conditions
Breast Neoplasms
17
Prostatic Neoplasms
16
Neoplasms
7
Head and Neck Neoplasms
7
Brain Neoplasms
7
Glioma
5
Colonic Neoplasms
5
Squamous Cell Carcinoma of Head and Neck
3
Spinal Cord Neoplasms
3
Pancreatic Neoplasms
3
Lymphoma
3
Lung Neoplasms
3
Astrocytoma
3
Uterine Cervical Neoplasms
2
Urinary Bladder Neoplasms
2
Triple Negative Breast Neoplasms
2
Rectal Neoplasms
2
Oligodendroglioma
2
Neurofibromatosis 1
2
Lymphoma, Non-Hodgkin
2
Glioblastoma
2
Disease
2
Central Nervous System Neoplasms
2
Carcinoma, Neuroendocrine
2
Carcinoma, Hepatocellular
2
Vasculitis
1
Thoracic Neoplasms
1
Thoracic Diseases
1
Testicular Neoplasms
1
Spinal Diseases
1
Interventions
Cyclophosphamide
16
fludarabine phosphate
13
Peripheral Blood Stem Cell Transplantation
13
Whole-Body Irradiation
10
Cyclosporine
10
Antilymphocyte Serum
9
Melphalan
8
Busulfan
8
Mycophenolic Acid
7
Filgrastim
6
fludarabine
5
Radiotherapy
5
Methotrexate
5
Etoposide
5
Psychiatric Rehabilitation
4
Methylprednisolone
4
Cytarabine
4
Carmustine
4
Blood Specimen Collection
4
thymoglobulin
3
Therapeutics
3
Rituximab
3
Flow Cytometry
3
Aprepitant
3
Analgesia
3
Tacrolimus
2
Stem Cell Transplantation
2
Proton Therapy
2
Polymerase Chain Reaction
2
Ondansetron
2
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Phase NA
×
Hodgkin Disease
×
Magnetic Resonance Imaging
×
Clear all
NCT05595577
2026-03-20
PALS
Wake Forest University Health Sciences
Phase NA
Recruiting
110 enrolled